Align Technology Appoints Raj Pudipeddi Chief Product And Marketing Officer, Senior Vice President and Managing Director of the Asia Pacific Region Succeeding Julie Tay, Senior Vice President and Managing Director of Asia Pacific Who Will Remain an Executi
September 02 2021 - 4:00PM
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical
device company that designs, manufactures, and sells the Invisalign
system of clear aligners, iTero intraoral scanners, and exocad
CAD/CAM software for digital orthodontics and restorative
dentistry, today announced that Raj Pudipeddi, Align Technology
chief product and marketing officer, and senior vice president
will assume additional responsibility for the commercial
organization in the Asia Pacific region as managing director,
effective immediately, succeeding Julie Tay, Align Technology
senior vice president and managing director, Asia Pacific. Ms. Tay
will remain an Align executive in the role of senior vice
president, commercial strategy through February 2022 to enable a
smooth transition and provide support for the Company’s annual
strategic planning process.
“I want to thank Julie for her lasting
contributions to Align and our Asia Pacific business which has
grown exponentially over the past eight years under her
leadership,” said Joe Hogan, Align Technology president and CEO.
“Throughout her tenure, Julie built a strong Asia Pacific
organization, whose leadership will work closely with Julie and Raj
to ensure a smooth transition, delivering on our strategic growth
initiatives across the region. We are fortunate that Julie will
remain through February and impart her extensive commercial
experience and insights as we evolve the strategies for several of
our emerging high growth markets globally. On behalf of our board
of directors and executive management team, I wish Julie the very
best. At the same time, I am pleased that Raj will expand his scope
to include management of our Asia Pacific business. Raj has
strengthened our product, innovation and marketing teams over the
last two and half years. His invaluable experience from previous
leadership positions in the Asia Pacific region make him ideal to
further strengthen our commercial operations. This is an exciting
time for Align, especially in Asia Pacific where the growth
opportunity across products, customer channels and markets remains
immense.”
Raj Pudipeddi joined Align in 2019 as senior
vice president and chief marketing officer. Mr. Pudipeddi is
responsible for the global product, marketing, innovation, business
development and clinical teams. Mr. Pudipeddi has 26 years of
business leadership and brand building experience across consumer
goods and telecom. He started his career at Procter & Gamble
and served in a number of leadership roles across businesses in
North America, Asia and Latin America. Most recently, he served as
chief marketing officer and director, Consumer Business at Bharti
Airtel, an Indian telecom leader. Mr. Pudipeddi earned an M.B.A.
degree from the Indian Institute of Management, Lucknow, India, and
a Bachelor of Engineering degree from the Gandhi Institute of
Technology in India.
Julie Tay joined Align in 2013 as vice president
and managing director of the Asia Pacific region, where she
successfully drove Align’s strategy to build the Asia Pacific
business by acquiring regional distributors and investing in sales,
marketing, and clinical operations - including establishing the
first training centers in the region. During this period, Align
opened its first treatment planning and aligner manufacturing
facilities in China to support rapid growth and adoption in China
initially and has expanded to support other country markets in Asia
Pacific.
The Company also announced today that Srini
Kaza, Align Technology vice president of product research &
development has been promoted to senior vice president, reporting
directly to Align president and CEO Joe Hogan. Mr. Kaza previously
reported to Raj Pudipeddi. As senior vice president of product
research & development, Mr. Kaza is responsible for a broad
range of technologies (biomechanics, CAD, CAM, advanced materials,
3D software algorithms, emerging technologies, clinical affairs)
specifically focused on driving product innovation and improving
product performance across the Invisalign portfolio, as well as
investigating next generation and state of the art manufacturing
technologies, working with software teams to envision and develop
several 3D CAD tools - and other innovations. Mr. Hogan continued,
“Product technology and innovation are core to Align and I am
thrilled to have Srini join the executive team. Over the past 22
years, Srini has been responsible for delivering significant
innovations, each with increasing complexity and sophistication,
resulting in continued growth and adoption of the Invisalign system
globally. As Align’s first manufacturing engineer, Srini developed
several technologies and processes that created the building blocks
for Align’s unmatched manufacturing scale, including a rapid
manufacturing process using stereolithography (3D printing)
technology, a 3D scanning process, and led development of key
technologies and processes that significantly improved performance
of the Invisalign system. I am looking forward to working with
Srini and his team as we develop the next generation of product
technology and innovations that enable the Align Digital
Platform.”
About Align Technology,
Inc.
Align Technology designs and manufactures
the Invisalign® system, the most advanced clear aligner system in
the world, iTero® intraoral scanners and services, and exocad®
CAD/CAM software. These technology building blocks enable enhanced
digital orthodontic and restorative workflows to improve patient
outcomes and practice efficiencies for over 200 thousand doctor
customers and is key to accessing Align’s 500 million consumer
market opportunity worldwide. Align has helped doctors treat
approximately 10.9 million patients with the Invisalign system and
is driving the evolution in digital dentistry through the Align
Digital Platform, our integrated suite of unique, proprietary
technologies and services delivered as a seamless, end-to-end
solution for patients and consumers, orthodontists and GP dentists,
and lab/partners. Visit www.aligntech.com for more information.
For additional information about the Invisalign
system or to find an Invisalign doctor in your area, please visit
www.invisalign.com. For additional information about the iTero
digital scanning system, please visit www.itero.com. For additional
information about exocad dental CAD/CAM offerings and a list of
exocad reseller partners, please visit
www.exocad.com.Forward-Looking Statements
This news release contains forward-looking statements, including
quotations from management regarding the size of growth
opportunities in the Asian Pacific markets, including for Align’s
products and in its customer channels, Align’s strategic growth
initiatives and commercial operations in the Asia Pacific region,
the transition from Ms. Tay to Mr. Pudipeddi, and Align’s next
generation product technology and innovations and other similar
comments or statements that may be forward-looking in nature.
Forward-looking statements contained in this news release relating
to expectations about future events or results are based upon
information available to Align as of the date hereof. Readers are
cautioned that these forward-looking statements are only
predictions and are subject to risks, uncertainties, and
assumptions that are difficult to predict. As a result, actual
results may differ materially and adversely from those expressed in
any forward-looking statement.
Factors that might cause such a difference
include, but are not limited to:
- the impact of the COVID-19 pandemic on the health and safety of
our employees, customers, patients, and our suppliers, as well as
the physical and economic impacts of the various recommendations,
orders, and protocols issued by local and national governmental
agencies in light of continual evolution of the pandemic, including
any periodic reimplementation of preventative measures in various
global locations;
- difficulties predicting customer and consumer purchasing
behavior and changes in consumer spending habits as a result of,
among other things, prevailing economic conditions, levels of
employment, salaries and wages, and consumer confidence,
particularly in light of the pandemic and as pandemic-related
restrictions are eased regionally and globally;
- unexpected or rapid changes in the growth or decline of our
domestic and/or international markets;
- increasing competition from existing and new competitors;
- rapidly evolving and groundbreaking advances that fundamentally
alter the dental industry or the way new and existing customers
market and provide products and services to consumers;
- the ability to protect our intellectual property rights;
- continued compliance with regulatory requirements;
- declines in, or the slowing of the growth of, sales of our
intraoral scanners domestically and/or internationally and the
impact either would have on the adoption of Invisalign
products;
- the willingness and ability of our customers to maintain and/or
increase product utilization in sufficient numbers;
- the possibility that the development and release of new
products or enhancements to existing products do not proceed in
accordance with the anticipated timeline or may themselves contain
bugs or errors requiring remediation and that the market for the
sale of these new or enhanced products may not develop as
expected;
- a tougher consumer demand environment in China generally,
especially for manufacturers and service providers whose
headquarters or primarily operations are not based in China;
- the risks relating to our ability to sustain or increase
profitability or revenue growth in future periods (or minimize
declines) while controlling expenses;
- the impact of excess or constrained capacity at our
manufacturing and treat operations facilities and pressure on our
internal systems and personnel;
- the compromise of customer and/or patient data for any
reason;
- the timing of case submissions from our doctors within a
quarter as well as an increased manufacturing costs per case;
- foreign operational, political and other risks relating to our
international manufacturing operations; and
- the loss of key personnel or work stoppages.
The foregoing and other risks are detailed from
time to time in our periodic reports filed with the Securities and
Exchange Commission, including, but not limited to, our Annual
Report on Form 10-K for the year ended December 31, 2020, which was
filed with the Securities and Exchange Commission (SEC) on February
26, 2021 and our latest Quarterly Report on Form 10-Q for the
quarter ended June 30, 2021, which was filed with the SEC on August
4, 2021. Align undertakes no obligation to revise or update
publicly any forward-looking statements for any reason.
Align Technology |
Zeno Group |
Madelyn Homick |
Sarah Johnson |
(408) 470-1180 |
(828) 551-4201 |
mhomick@aligntech.com |
sarah.johnson@zenogroup.com |
Align Technology (NASDAQ:ALGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Align Technology (NASDAQ:ALGN)
Historical Stock Chart
From Apr 2023 to Apr 2024